GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Buy MDT
up 91.01 %

Medtronic, Inc. (MDT) rated Buy with price target $47 by Brean Murray

Posted on: Wednesday,  Feb 22, 2012  8:25 AM ET by Brean Murray

Brean Murray rated Buy Medtronic, Inc. (NYSE: MDT) on 02/22/2012. Previously Brean Murray rated Buy Medtronic, Inc. (NYSE: MDT) on 06/15/2011.,
when the stock price was $38.49. Since then, Medtronic, Inc. has gained 91.01% as of 08/27/2015's recent price of $73.52.
If you would have followed the previous Brean Murray's recommendation on MDT, you would have gained 91.01% of your investment in 1534 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/22/2012 8:25 AM Buy
None
38.04 47.00
as of 12/31/2012
1 Week down  -1.63 %
1 Month down  -2.58 %
3 Months down  -4.87 %
1 YTD up  7.24 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/23/2011 8:25 AM Buy
None
34.44 42.00
6/15/2011 8:25 AM Buy
None
38.49 44.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy